259P Weekly ladiratuzumab vedotin monotherapy for metastatic triple-negative breast cancer

Autor: Tsai, M., Han, H.S., Montero, A.J., Tkaczuk, K.H., Assad, H., Pusztai, L., Hurvitz, S.A., Wilks, S.T., Specht, J.M., Nanda, R., Mita, M., O'Shaughnessy, J., Krop, I.E., Medgyesy, D., Abraham, J., Modi, S., Li, H., Wu, S., Garfin, P.M., Burris, H.A., III
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S474-S475
Databáze: ScienceDirect